Amphastar Pharmaceuticals AMPH Q1 2026 Earnings Significant EPS Miss Fails to Dampen Stock Sentiment WERN Q1 2026 Earnings EPS Surges Past Estimates Marking a Strong Turnaround Nyxoah SA NYXH Q1 2026 Earnings NarrowerThanExpected Loss as Company Advances Sleep Apnea Platform WRB Q1 2026 Earnings Strong EPS Beat Driven by Solid Underwriting and Investment Results NB Q1 2026 Earnings Surprise Profit Highlights Cost Discipline at PreRevenue Developer DDL Q4 2025 Earnings Profitability Milestone Despite Mixed Market Signals